Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care AG & Co. KGaA (ticker: FMS) is a global healthcare company specialising in dialysis services and products. It operates a network of renal care clinics and supplies machines, disposables and associated therapies. Investors should note the business combines recurring-revenue clinic treatments with product sales, which can provide steady cash flow but also ties performance to patient volumes, reimbursement rates and product adoption. Demographic trends such as ageing populations support long-term demand, while regulatory oversight, reimbursement pressures and operational complexity are meaningful risks. Financial specifics such as market capitalisation and recent results change frequently β€” check current market data before making decisions. This summary is for general educational purposes only and not personalised investment advice; values can rise and fall and past performance does not guarantee future returns. Consider your risk tolerance and investment horizon when assessing any position in FMS.

Stock Performance Snapshot

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring FMS

German Stocks Soaring

German Stocks Soaring

Discover a carefully selected collection of German companies that have been dramatically outperforming their western counterparts. Our team of professional analysts has identified these standout stocks as Germany's economy shows promising signs of growth in 2025.

Published: May 15, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Steady service demand

Dialysis treatments create recurring revenue that can support predictability, though volumes and reimbursement rates can change.

🌍

Global footprint matters

A wide clinic network offers growth and diversification but also exposes the company to regulatory and currency risks across regions.

⚑

Product and tech focus

Innovation in machines and consumables can improve margins and outcomes, yet competition and R&D costs add uncertainty.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions